Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (NASDAQ: GDRX) is widely described as the leading platform for medication savings in the U.S., and its news flow reflects that role at the intersection of digital healthcare, pharmacy, and pharmaceutical manufacturers. Company announcements highlight new partnerships, product launches, and financial updates that shape how consumers, pharmacies, and manufacturers approach prescription affordability.
News about GoodRx often covers collaborations with major healthcare players. Examples include the RxSmartSaver program powered by GoodRx at national and regional retail pharmacies, which brings brand medication savings directly to the pharmacy counter, and an exclusive partnership with Surescripts that integrates GoodRx discounted cash prices into Script Corner, a patient experience product focused on prescription price transparency.
GoodRx also issues press releases on new consumer offerings and subscriptions. Recent updates describe GoodRx for Weight Loss, a telemedicine subscription for GLP-1 weight management treatment, and GoodRx for Hair Loss, a subscription program for men that combines virtual consultations, prescriptions for oral finasteride or oral minoxidil when appropriate, and discreet home delivery. Additional news highlights defined cash prices for medications such as Repatha, Ozempic, Wegovy, and the Wegovy pill at tens of thousands of pharmacies nationwide via GoodRx.
Investors and observers can also find earnings-related news, including quarterly financial results, guidance commentary, and participation in healthcare conferences. Together, these updates provide insight into GoodRx’s strategy across prescription transactions, subscriptions, pharma manufacturer solutions, and telehealth. For anyone tracking GDRX, this news page offers a focused view of how the company is evolving its platform, expanding partnerships, and addressing medication affordability across the U.S. healthcare system.
GoodRx Holdings has announced a new share repurchase program authorized to buy back up to $250 million of its Class A Common Stock. The program aims to enhance shareholder value and reflects the company's confidence in its future growth. Repurchases will be executed based on market conditions, using existing cash and cash equivalents, with reports indicating $941.1 million in cash available as of December 31, 2021. The program is effective immediately and may be modified or terminated by the Board at their discretion before February 23, 2024.
GoodRx Holdings Inc. (NASDAQ: GDRX) announced its participation in key investor conferences in March. Executives will present at the Raymond James 43rd Annual Institutional Investors Conference in Orlando, FL, on March 8 at 7:25 a.m. PT; at the Cowen 42nd Annual Health Care Conference virtually on March 9 at 8:10 a.m. PT; and at the Deutsche Bank 30th Annual Media, Internet & Telecom Conference in Palm Beach, FL, on March 15 at 6:35 a.m. PT. Live webcasts and archived recordings will be accessible via their Investor Relations website.
GoodRx Holdings Inc. (NASDAQ: GDRX) will release its fourth quarter and full year 2021 financial results after U.S. markets close on February 28, 2022. A conference call will occur at 2:00 p.m. PT to discuss the results and future outlook. The financial results will be available on their investor relations website. GoodRx, a leading digital healthcare platform, has helped consumers save over $35 billion since 2011, establishing itself as a crucial resource for affordable healthcare.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). A live webcast of the presentation will be accessible via the Company’s Investor Relations website, and an archived recording will be available for at least 30 days post-conference. Since its inception in 2011, GoodRx has helped Americans save over $35 billion, making healthcare more affordable and convenient.
GoodRx Holdings Inc. (NASDAQ: GDRX) has announced participation in two upcoming investor conferences. The first is the Credit Suisse 25th Annual Technology Conference on December 1, 2021, at 1:20 p.m. PT in Scottsdale, AZ. The second is the Barclays Global Technology, Media and Telecommunications Conference on December 7, 2021, at 11:25 a.m. PT, held virtually. Live webcasts and presentation materials will be accessible on the Company's Investor Relations website, with archived recordings available for 30 days post-conference.
GoodRx has released its State of Telehealth report, highlighting significant changes in telehealth usage due to the COVID-19 pandemic. Over 1,600 providers and patients were surveyed, revealing that 40% of consumers feel they interact more with providers via telehealth. Additionally, 70% of providers noted improved continuity of care. Post-pandemic, 60% of consumers plan to adopt a hybrid model of care. While 45% of providers reported higher no-show rates for telehealth appointments, overall satisfaction remains high, with GoodRx's telehealth service achieving a 92% satisfaction rate and saving consumers an estimated $243 million in medical costs.
GoodRx Holdings, Inc. (GDRX) announced its third quarter 2021 financial results, highlighting its role as a digital healthcare resource that has saved consumers $35 billion since inception in 2011. The company hosted a conference call on November 10, 2021, at 2:00 PM PT to discuss these results and its business outlook. GoodRx is recognized as one of the most downloaded medical apps, emphasizing its significant impact on healthcare affordability and access in the U.S.
GoodRx Holdings Inc. (NASDAQ: GDRX) will release its third quarter 2021 financial results on November 10, 2021, after U.S. market close. A conference call will follow at 2:00 p.m. PT (5:00 p.m. ET), discussing the results and future business outlook. A press release with a link to a shareholder letter will be available on their investor relations website prior to the call. GoodRx, since its inception in 2011, has saved consumers over $30 billion in healthcare costs and remains a leading medical app in the U.S.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the Morgan Stanley Annual Spark Conference on Thursday, October 14, at 1:15 p.m. PT in Beverly Hills, CA. The presentation can be streamed live via the Company's Investor Relations website, with an archived version available for at least 30 days afterward. GoodRx is a digital healthcare resource that has saved consumers over $30 billion since 2011, aiming to make healthcare affordable and accessible for all Americans.
GoodRx has partnered with Fetch Rewards, enabling its 10 million active users to earn rewards points when using GoodRx coupons for medications. This collaboration allows users to access significant medication discounts at over 70,000 pharmacies nationwide, with potential savings of up to 80%. Fetch users can seamlessly integrate these savings and receive rewards that may be redeemed for gift cards or donations. The partnership aims to support millions who struggle with medication affordability and enhance user engagement through Fetch's loyalty program.
FAQ
What is the current stock price of Goodrx Holdings (GDRX)?
What is the market cap of Goodrx Holdings (GDRX)?
